SNPMiner Trials (Home Page)
Report for Mutation M1040E
Developed by Shray Alag, 2020.
SNP Clinical Trial Gene
There is one clinical trial.
Clinical Trials
1 AHRQ Health Services Research Projects: Making Health Care Safer in Ambulatory Care Settings and Long Term Care Facilities
This prospective cohort study seeks to determine if the ECHO-CT program, a healthcare videoconferencing program, can improve clinical outcomes while reducing cost and resource utilization when expanded to a community hospital setting. Data will be analyzed on the facility level and patient level.
NCT03832257 Acute Disease Other: ECHO CT Intervention Other: Matched Non-Participating Facilities MeSH:Acute Disease
From the MDS (variable codes in parentheses), including rates of dehydration (J1550C), internal bleeding (J1550D), falls (J1800), anti-psychotic medication use (N0400A), delirium (C1300), surgical wound infections (I2500 and M1040E), pressure ulcers (M0210), and uncontrolled pain (J0850).. Health Care Cost. --- M1040E ---
Primary Outcomes
Description: Number of hospital readmissions over 30 day period among participating SNF sites
Measure: 30-Day Readmission Rates Time: 30-DaysSecondary Outcomes
Description: Includes average length of stay in the facility
Measure: Health Care Utilization Time: up to 90 daysDescription: From the MDS (variable codes in parentheses), including rates of dehydration (J1550C), internal bleeding (J1550D), falls (J1800), anti-psychotic medication use (N0400A), delirium (C1300), surgical wound infections (I2500 and M1040E), pressure ulcers (M0210), and uncontrolled pain (J0850).
Measure: Incidence of Adverse Clinical Conditions Time: 30 DaysDescription: Total 30-day Medicare costs for fee-for-service patients.
Measure: Health Care Cost Time: 30-days